|
Market Closed -
Nasdaq
16:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 23.26 USD | -2.08% |
|
-3.86% | +40.91% |
| 08-25 | B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating | MT |
| 08-24 | FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome | RE |
Stock exchange
Nasdaq
DNLI 23.26 $
-2.08%
33.31M
$
Quotes 5-day view: Denali Therapeutics Inc.
Delayed Quote Nasdaq| 2026-08-26 | 2026-08-27 | 2026-08-28 | 2026-08-31 | 2026-09-01 | |
|---|---|---|---|---|---|
| Last | US$24.57 | US$24.67 | US$24.00 | US$23.76 | US$23.27 |
| Volume | 771,265 | 700,114 | 807,598 | 985,862 | 1,431,668 |
| Change | -1.44% | +0.41% | -2.72% | -1.00% | -2.08% |
| Opening | US$24.75 | US$24.43 | US$24.42 | US$23.72 | US$23.44 |
| High | US$24.89 | US$24.74 | US$24.62 | US$24.01 | US$23.75 |
| Low | US$24.33 | US$24.16 | US$23.92 | US$23.41 | US$23.06 |
Performance
| 1 day | -2.08% | ||
| 1 week | -3.86% | ||
| Current month | -2.08% | ||
| 1 month | +1.06% | ||
| 3 months | +10.58% | ||
| 6 months | +9.84% | ||
| Current year | +40.91% | ||
| 1 year | +52.36% | ||
| 3 years | +0.76% | ||
| 5 years | -56.27% |
Volumes
marketsDaily volume
1,431,668
Estimated daily volume
1,431,668
Avg. Volume 20 sessions
1,067,935
Daily volume ratio
1.34
Avg. Volume 20 sessions USD
24,845,507.78
Record volume 1
6,526,874
Record volume 2
6,306,715
Record volume 3
6,063,669
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
3,797,974,295
Net sales (USD)
0
Number of employees
503
Sales / Employee (USD)
0
Free-Float
90.03 %
Free-Float capitalization (USD)
3,419,466,090
Average Daily Capital Traded
0.65%
Indicators
Moving average 5 days
24.39
Moving average 20 days
24.6
Moving average 50 days
24.57
Moving average 100 days
22.28
Price spread / (MMA5)
+4.82%
Price spread / (MMA20)
+5.75%
Price spread / (MMA50)
+5.59%
Price spread / (MMA100)
-4.22%
STIM
RSI 9 days
42.87
RSI 14 days
46.67
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.08% | -3.86% | +52.36% | +0.76% | 3.8B | ||
| -0.25% | -0.92% | +49.47% | +89.45% | 68.13B | ||
| +1.21% | +2.55% | +46.72% | +90.66% | 63.6B | ||
| +1.31% | +1.81% | +49.04% | +12.07% | 25.57B | ||
| -0.25% | -1.99% | -10.72% | +455.09% | 26.6B | ||
| +0.33% | -9.64% | +1.95% | -15.70% | 25.52B | ||
| -6.09% | -11.19% | +224.80% | +351.08% | 18.23B | ||
| +1.18% | +1.66% | +35.20% | -18.67% | 19.69B | ||
| -1.49% | -6.35% | +7.84% | +540.26% | 15.16B | ||
| +4.12% | +4.29% | +52.03% | +154.09% | 13.54B | ||
| Average | -0.20% | -3.64% | +50.87% | +165.91% | 27.98B | |
| Weighted average by Cap. | +0.12% | -2.85% | +47.07% | +143.61% |
Historical Quotes: Denali Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
6af7f2a9422.KkgwGZhIkX-0iORE3Zu4wXIxL0bKw-1WKPv4UcV_0xw.UBh1VMokyDrl_KwcmbaIhQcHWRf-nKAwfI_LEIoulVJECXdp9g3YHvrgsQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 23.26 | 206,920 | 1,048,441 |
| 15:59:58 | 23.26 | 100 | 841,521 |
| 15:59:58 | 23.26 | 332 | 841,421 |
| 15:59:58 | 23.26 | 122 | 841,089 |
| 15:59:58 | 23.26 | 100 | 840,967 |
| 15:59:58 | 23.26 | 100 | 840,867 |
| 15:59:58 | 23.26 | 100 | 840,767 |
| 15:59:57 | 23.25 | 100 | 840,667 |
| 15:59:57 | 23.25 | 100 | 840,567 |
| 15:59:56 | 23.26 | 100 | 840,467 |
Price Extremes
| 1 week | 23.06 | 24.89 | |
| 1 month | 22.63 | 25.74 | |
| Current year | 15.34 | 27.3 | |
| 1 year | 12.58 | 27.3 | |
| 3 years | 10.57 | 33.33 | |
| 5 years | 10.57 | 56.8 | |
| 10 years | 10.57 | 93.94 |
Monthly variations
Annual variations
| 2026 | +40.91% | ||
| 2025 | -18.99% | ||
| 2024 | -5.03% | ||
| 2023 | -22.83% | ||
| 2022 | -37.65% | ||
| 2021 | -46.75% | ||
| 2020 | +380.83% | ||
| 2019 | -15.68% | ||
| 2018 | +32.10% | ||
| 2017 | -27.09% |
- Stock Market
- Stocks
- DNLI Stock
- Quotes Denali Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions

















